Invesco Ltd. Kala Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $4,701 - $20,529	-15,671 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $7,560 - $17,859	-6,518 Reduced 29.37%	15,671 $19,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $8,245 - $17,088	3,147 Added 16.53%	22,189 $58,000
Q2 2021 Aug 17, 2021	BUY	$5.06 - $8.15 $96,352 - $155,192	19,042 New	19,042 $101,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $2.82 Million - $4.18 Million	-376,286 Closed	0 $0

Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $30,104 - $49,837	3,614 Added 0.97%	376,286 $3.95 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $1.43 Million - $3.28 Million	372,672 New	372,672 $3.28 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.